Next Article in Journal
Anti-Influenza Virus (H5N1) Activity Screening on the Phloroglucinols from Rhizomes of Dryopteris crassirhizoma
Previous Article in Journal
A Palladium Catalyst System for the Efficient Cross-Coupling Reaction of Aryl Bromides and Chlorides with Phenylboronic Acid: Synthesis and Biological Activity Evaluation
Review

Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal

1
Laboratory of Biomaterials and Nanotechnology, University of Sorocaba (UNISO), Sorocaba, SP 18078-005, Brazil
2
Laboratory of Post-Graduate Program in Biotechnology and Environmental Monitoring (PPGBMA), University of São Carlos (UFSCAR), Sorocaba, SP 18052-780, Brazil
3
Laboratory of Biomaterials (LABIOMAT), Pontificial University Catholic (PUC), Sorocaba, SP 18030-070, Brazil
*
Author to whom correspondence should be addressed.
Academic Editor: Derek J. McPhee
Molecules 2017, 22(3), 419; https://doi.org/10.3390/molecules22030419
Received: 23 January 2017 / Accepted: 28 February 2017 / Published: 7 March 2017
The behavior of lyotropic biomimetic systems in drug delivery was reviewed. These behaviors are influenced by drug properties, the initial water content, type of lyotropic liquid crystals (LLC), swell ability, drug loading rate, the presence of ions with higher or less kosmotropic or chaotropic force, and the electrostatic interaction between the drug and the lipid bilayers. The in vivo interaction between LCC—drugs, and the impact on the bioavailability of drugs, was reviewed. The LLC with a different architecture can be formed by the self-assembly of lipids in aqueous medium, and can be tuned by the structures and physical properties of the emulsion. These LLC lamellar phase, cubic phase, and hexagonal phase, possess fascinating viscoelastic properties, which make them useful as a dispersion technology, and a highly ordered, thermodynamically stable internal nanostructure, thereby offering the potential as a sustained drug release matrix for drug delivery. In addition, the biodegradable and biocompatible nature of lipids demonstrates a minimum toxicity and thus, they are used for various routes of administration. This review is not intended to provide a comprehensive overview, but focuses on the advantages over non modified conventional materials and LLC biomimetic properties. View Full-Text
Keywords: liquid crystals; lyotropic liquid crystals; biomimetic systems; immunodetection; drug carriers liquid crystals; lyotropic liquid crystals; biomimetic systems; immunodetection; drug carriers
Show Figures

Graphical abstract

MDPI and ACS Style

De Souza, J.F.; Pontes, K.D.S.; Alves, T.F.R.; Amaral, V.A.; Rebelo, M.D.A.; Hausen, M.A.; Chaud, M.V. Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal. Molecules 2017, 22, 419. https://doi.org/10.3390/molecules22030419

AMA Style

De Souza JF, Pontes KDS, Alves TFR, Amaral VA, Rebelo MDA, Hausen MA, Chaud MV. Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal. Molecules. 2017; 22(3):419. https://doi.org/10.3390/molecules22030419

Chicago/Turabian Style

De Souza, Juliana F., Katiusca D.S. Pontes, Thais F.R. Alves, Venâncio A. Amaral, Márcia D.A. Rebelo, Moema A. Hausen, and Marco V. Chaud. 2017. "Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal" Molecules 22, no. 3: 419. https://doi.org/10.3390/molecules22030419

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop